Expanded Access Policy

ITF Therapeutics does not have an investigational product candidate available for expanded access at this time in the US. We believe that participation in clinical trials, which are carefully designed to determine the safety and efficacy of an investigational therapy, is the most appropriate way for patients to access an investigational therapy until sufficient evidence is available that suggests the potential benefit outweighs the risk.